The “all hands on deck” responses to the Covid-19 pandemic have driven significant innovations in areas ranging from vaccine development and drug repurposing to diagnostic and antibody testing, telemedicine and contact tracing. At the same time, the pandemic has also prompted a relook at things like global supply chains, PPE strategic reserves and just in time inventories. Speakers and panelists will discuss preparations for future pandemics as well as the effects on current healthcare.


Time   Event
Registration and Breakfast
9:15-9:30am Welcome and Introduction
Dan Peterson, Vice President, Industry & Government Affairs, Cook Group
9:30-10:15am Keynote
Lindsay Weaver, MD, FACEP, Chief Medical Officer, Indiana State Department of Health
10:15 – 10:30am Break
10:30am – 12:00 pm Panel – Five Things Going Forward
Moderator: Neal Roach, Health Care & Life Sciences Industry Chair, Taft Stettinius & Hollister LLP
Chris Otto, Senior Director, Clinical Laboratory Services, Eli Lilly and Company
Erica Anderson, Population Health Strategy Lead, Office of Population Health, Humana
Denis Johnson, Vice President and General Manager, Catalent Pharma Solutions
Chris Kiple, CEO, Ventec Life Systems
Rusty Ring, Vice President Government Affairs, Roche Diagnostics
12:00-12:05 pm Wrap-up and Transition to Breakouts
George Telthorst, Director, Center for the Business of Life Sciences, IU-Kelley School of Business
12:05 – 12:15 pm Break
12:15-1:00 pm Breakout Session(s) Over Lunch with the morning speakers
Add to your Calendar: Add to Google CalendarAdd to Outlook / Download ICS